COHERUS ONCOLOGY INC
CHRSNASDAQ🏆 #3428 by market capEarnings Nov 5US Equity
$1.19▼ $0.02 (−1.65%)
Live1h▼ 2.9%
24h▼ 1.6%
7d▼ 17.9%
14d▼ 15.6%
30d▼ 19.6%
1y▲ 30.1%
🏦Market Cap
$184M
Small Cap
📈Revenue Growth (YoY)
-84.2%
Declining
📊Gross Margin
63.5%
High
💵FCF Margin
-478.9%
Thin
⚖️P/S Ratio
3.7x
Fair
Otter Score
51
Weak
Earnings
Q3 · 2026Reported 2026-08-05Earnings Per Share
Actual
-0.19
Expected
-0.25
beat
+24.00%
YoY +44.10%
Revenue
Actual
$14.31M
Expected
$14.41M
miss
−0.70%
YoY +39.50%
Consensus estimates
Recent quarters
Q3 2026
-0.19
beat
Q2 2026
-0.25
beat
Q1 2026
-0.34
beat
Q4 2025
-0.33
miss